SL
RGEN icon

Summitry LLC’s Repligen RGEN Stock Holding History

Summitry LLC’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Buy
2,385
+644
+37% +$90K 0.01% 221
2025
Q4 		$285K Buy
1,741
+244
+16% +$38.2K 0.01% 188
2025
Q3 		$200K Buy
+1,497
New +$182K 0.01% 215

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Summitry LLC's RGEN Position: Q1 2026 in Review

Summitry LLC increased its Repligen (RGEN) stake by 37% in Q1 2026, buying an estimated $90K and bringing the position to 2,385 shares worth $281K. The position accounts for 0.01% of the portfolio, ranked #221.

Summitry LLC first reported a position in RGEN in Q3 2025 and has held it in 3 quarters since. The position peaked at $285K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Summitry LLC held 2,385 shares of Repligen worth $281K as of Q1 2026.
  • Summitry LLC bought 644 Repligen shares in Q1 2026, an estimated $90K.
  • Repligen made up 0.01% of Summitry LLC's portfolio in Q1 2026, its #221 holding.
  • Summitry LLC first reported a position in Repligen in Q3 2025 and has held it in 3 quarters since.
  • Summitry LLC's Repligen position peaked at $285K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Summitry LLC's 13F filing for Q1 2026, filed 11 May 2026.